𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Quantitative measurement of cervical range of motion in patients with torticollis treated with botulinum A toxin

✍ Scribed by Dr. Dennis Dykstra; Corine Ellingham; Albert Belfie; Tanya Baxter; Myoung Lee; Ann Voelker

Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
759 KB
Volume
8
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Improvement in cervical range of motion in patients with spasmodic torticollis by botulinum A toxin injection is difficult to objectively measure. Recently, a three‐dimensional cervical range of motion system (EMROM) that measures primary as well as secondary cervical angles has been developed. This system uses an electromagnetic tracking system for data collection and a personal computer for analysis and graphic display of the data. We have tested the EMROM system and, from our results, believe that it can be used clinically to objectively and accurately measure cervical range of motion in patients who have spasmodic torticollis and who receive botulinum toxin injections.

πŸ“œ SIMILAR VOLUMES

Use of botulinum toxin type F injections
Use of botulinum toxin type F injections to treat torticollis in patients with immunity to botulinum toxin type A
✍ Dr. Paul E. Greene; Stanley Fahn πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 492 KB

## Abstract Fifteen patients with torticollis who had been treated with repeated injections of botulinum toxin type A (botox A) developed antibodies to the toxin. This resulted in loss of benefit in the 13 patients who had improved with botox A injections and failure to develop muscle atrophy after

Development of resistance to botulinum t
Development of resistance to botulinum toxin type A in patients with torticollis
✍ Dr. Paul Greene; Stanley Fahn; Beverly Diamond πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 453 KB

## Abstract Between 1984 and 1992, 559 patients with torticollis were treated with botulinum toxin type A (btx) injections. Twenty‐four of these 559 patients (4.3%) had serological evidence of antibodies to btx by mouse neutralization assay. Some of the 559 patients had only one or two injection se

Long-term follow-up of cervical dystonia
Long-term follow-up of cervical dystonia patients treated with botulinum toxin A
✍ Peter Haussermann; Stefanie Marczoch; Christiane Klinger; Michael Landgrebe; Bas πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 621 KB

## Abstract We followed the course in 100 consecutive patients with cervical dystonia (CD) after they were initially treated with botulinum toxin (BTX) in the form of Dysport 10 to 12 years ago. A total of 4 patients had died, and 6 were lost to follow‐up. Of the remaining 90 patients, 57 (63%) wer

Quantitative assessment of botulinum tox
Quantitative assessment of botulinum toxin treatment in 43 patients with head tremor
✍ JΓΆrg Wissel; Florian Masuhr; Ludwig Schelosky; Georg Ebersbach; Werner Poewe πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 364 KB

## Abstract We treated 43 patients who had head tremor as the major complaint with local botulinum toxin type A (Btx A) injections into neck muscles: 29 patients were classified as suffering from tremulous cervical dystonia (TCD), and 14 had head tremor without dystonia (HT). All patients were clin